$6.47
0.00% yesterday
Nasdaq, Mar 31, 03:30 pm CET
ISIN
AGP8696W1045
Symbol
SVA
Sector
Industry

Sinovac Biotech Ltd. Stock price

$6.47
+0.00 0.00% 1M
+0.00 0.00% 6M
+0.00 0.00% YTD
+0.00 0.00% 1Y
+0.00 0.00% 3Y
+0.00 0.00% 5Y
+1.51 30.44% 10Y
Nasdaq, Closing price Mon, Mar 31 2025
+0.00 0.00%
ISIN
AGP8696W1045
Symbol
SVA
Sector
Industry

Key metrics

Market capitalization $464.94m
Enterprise Value $-6.93b
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF 17.26
EV/Sales (TTM) EV/Sales -16.15
P/S ratio (TTM) P/S ratio 1.08
P/B ratio (TTM) P/B ratio 0.07
Revenue growth (TTM) Revenue growth 1.98%
Revenue (TTM) Revenue $429.20m
EBIT (operating result TTM) EBIT $-392.28m
Free Cash Flow (TTM) Free Cash Flow $-401.60m
EPS (TTM) EPS $-1.31
Short interest 0.26%
Show more

Is Sinovac Biotech Ltd. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,804 stocks worldwide.

Sinovac Biotech Ltd. Stock Analysis

Unlock Scores for Free

Analyst Opinions

1 Analyst has issued a forecast Sinovac Biotech Ltd.:

1x Buy
100%

Analyst Opinions

1 Analyst has issued a forecast Sinovac Biotech Ltd.:

Buy
100%

Financial data from Sinovac Biotech Ltd.

Income Statement P&L | Balance Sheet | Cash Flow


TTM Annually
Jun '24
+/-
%
429 429
2% 2%
100%
- Direct Costs - -
-
-
- -
-
-
- Selling and Administrative Expenses 218 218
71% 71%
51%
- Research and Development Expense 337 337
17% 17%
79%
-262 -262
81% 81%
-61%
- Depreciation and Amortization 130 130
20% 20%
30%
EBIT (Operating Income) EBIT -392 -392
74% 74%
-91%
Net Profit -125 -125
65% 65%
-29%

In millions USD.

Don't miss a Thing! We will send you all news about Sinovac Biotech Ltd. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Sinovac Biotech Ltd. Stock News

Neutral
Business Wire
about 13 hours ago
BEIJING--(BUSINESS WIRE)--Sinovac Biotech Ltd. (NASDAQ: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today announced that the Company's board of directors (the “Board”) has decided to declare a special cash dividend of US$55.00 per common share (the “Dividend”). The Board expects to fund the Dividend from available cash resources of the Company a...
Neutral
Business Wire
4 days ago
BEIJING--(BUSINESS WIRE)--Sinovac Biotech Ltd. (NASDAQ:SVA) ("SINOVAC" or the "Company"), a leading provider of biopharmaceutical products in China, today announced that its board of directors (the “Board”) has appointed Sven H. Borho, CFA, as director to the Board to fill in a vacancy created by a recent resignation. As a qualified audit committee financial expert under Nasdaq Rule 5605, Mr. B...
Neutral
PRNewsWire
12 days ago
BOSTON , March 20, 2025 /PRNewswire/ -- Sinovac Biotech Ltd. (NASDAQ: SVA) ("Sinovac") shareholder Heng Ren Partners, LLC funds ("Heng Ren") today sent an open letter to Sinovac's shareholders outlining the significant and decisive action that Sinovac's Board of Directors must take to create liquidity and release cash to shareholders.
More Sinovac Biotech Ltd. News

Company Profile

Sinovac Biotech Ltd. is a holding company, which engages in the research, development, manufacture, and commercialization of vaccines that protect against human infectious diseases. Its product portfolio includes vaccines against enterovirus71, or EV71, hepatitis A and B, seasonal influenza, H5N1 pandemic influenza, H1N1 influenza, and mumps. The company was founded in 1993 and is headquartered in Beijing, China.

Head office Antigua and Barbuda
CEO Wei Yin
Employees 3,037
Founded 1993
Website www.sinovac.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today